Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank56
3Y CAGR-84.4%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-84.4%/yr
Annual compound
Percentile
P56
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 2.16% |
| 2024 | 69.52% |
| 2023 | 8.34% |
| 2022 | 570.03% |
| 2021 | 873.82% |
| 2020 | -16.04% |
| 2019 | -1046.50% |
| 2018 | -921.43% |
| 2017 | -27.27% |
| 2016 | 0.00% |